Artivila Biopharma
PrivateLast Round
Series A
Jun 25, 2026
Total Funding Raised
$35.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Artivila Biopharma is a biotechnology company that develops innovative drugs for autoimmune diseases, neurodegenerative diseases, and oncology using an AI-driven drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artivila Biopharma Comparables
Compare Artivila Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindRank | 83% | |
| Terray Therapeutics | 79% | |
| Genesis Molecular AI | 79% |
Artivila Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 25, 2026 | ||||
| VC Round | Mar 31, 2022 | ||||
| Seed | Mar 30, 2021 | ||||
| Angel | Nov 1, 2019 |
Artivila Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Seed |
| Hike Capital | VC Round |
| Jiangsu Honghui Equity Investment Management | Seed |
| 幂方资本 | Seed |
| Bopu Asset Management | Angel |
| Anlong Fund | Angel |
| Yijing Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
$13M round led by Green Pine Capital Partners
- Sep 22, 2025
Successful completion of Phase I study for ARD-885, a novel small molecule drug.
Recent news
Latest coverage and updates
- receives_financingJun 25, 2026
Artivila received financing of $55M in cumulative funding on Jun 25th '26.
- receives_financingJun 25, 2026
Artivila received financing of $12.8M in Series A on Jun 25th '26.
Artivila Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Artivila Biopharma's valuation, stock price, and market status.
Is Artivila Biopharma a public or private company?
Artivila Biopharma is a private company.
What is the current stock price of Artivila Biopharma?
Artivila Biopharma is a private company with no public stock price. No recent secondary market data is available.
How much is Artivila Biopharma worth (valuation)?
Valuation information for Artivila Biopharma is not publicly available.
Can I buy Artivila Biopharma stock?
Artivila Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Artivila Biopharma's last funding round?
Artivila Biopharma's most recent funding round was Series A on June 25, 2026.
Who are the main investors in Artivila Biopharma?
Key investors in Artivila Biopharma include HighLight Capital, 松禾资本 (Green Pine Capital Partners).
Will Artivila Biopharma IPO soon?
No public IPO plans have been announced for Artivila Biopharma.
How can I track Artivila Biopharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Artivila Biopharma's secondary market activity and sign up for updates.